CN204473327U - A kind of eye drop bottle new structure - Google Patents
A kind of eye drop bottle new structure Download PDFInfo
- Publication number
- CN204473327U CN204473327U CN201520135436.1U CN201520135436U CN204473327U CN 204473327 U CN204473327 U CN 204473327U CN 201520135436 U CN201520135436 U CN 201520135436U CN 204473327 U CN204473327 U CN 204473327U
- Authority
- CN
- China
- Prior art keywords
- bottle
- new structure
- eye drop
- bottle cap
- bottleneck
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A kind of eye drop bottle new structure, comprises bottle, bottleneck, bottle cap, and described bottleneck connects bottle and bottle cap, there is the impression being easy to tear described bottle cap and bottleneck junction, be provided with opening board above bottle cap, opening board is fixedly connected with bottle cap, described bottle cross-sectional plane ovalize.The utility model adopts unit dose package, single use after opening, safe, convenient, healthy, can reduce drug waste, reduces medical waste and pollutes, relieve patient ' s burden.
Description
Technical field
The utility model relates to a kind of eye drop bottle, particularly disposable eye drop bottle.
Background technology
Traditional eye drops is the packaging of multiple dose, can Reusability after unlatching, and it mainly exists following problem:
1, containing anti fouling composition, easily cross pollution is produced
Anti fouling composition (Preservatives) is that a class prevents or the pharmaceutical chemicals of restriction micro-organisms growth and reproduction, traditional multiple dose eye drops production technology cannot guarantee the microbial contamination of eye drops in production, use procedure, for preventing the microbial contamination of medicament, anti fouling composition must be added in multiple dose eye drops.The use of anti fouling composition is very extensive, and nearly all multiple dose eye drops comprises in microbiotic eye drops and is all added with anti fouling composition, such as, all employ anti fouling composition in the eye drops such as rifampin, Ofloxacin, chloromycetin.But in actual applications, the selection of anti fouling composition kind and concentration, compatibility and improper use, all can cause pollution and the quality problems of eye drops, the health of serious threat patient.Use the eye drops containing anti fouling composition mainly can cause following harm:
A ﹑ corneal injury;
B ﹑ hypopsia;
C ﹑ wound healing is slow;
D ﹑ subject word marks the certain risk of incorrect initiation;
Multiple dose eye drops in use resting period, preservation condition, using method etc. is incorrect, all may produce certain risk.Different with the subject word of the formulation such as tablet, capsule, the subject word that eye drops is indicated refers to the effective time when not breaking a seal, and for opening the holding time of rear eye drops, a lot of specification sheets is not all indicated.Therefore, people usually can save backup unspent eye drops when using eye drops, and eye drops is sterile preparation, and its requirements for quality is equal to injection substantially, the preparation that must use at the appointed time after belonging to Kaifeng, places for a long time after should not breaking a seal.Generally, eye drops is opened rear sealing clean environment and is generally 1 week standing time, if overlong time, is easily caused new ocular infection by pathogen contamination.
The antimicrobial spectrum of 2 ﹑ anti fouling composition is narrow, weak effect
Shanghai City shows the investigation of 205 bottles of eye drops, and contamination rate is up to 37.1%, and the pollution rate of its Pseudomonas aeruginosa is 10%.Sun Xu light etc. shows the investigation of eye drop bottle eck microbial contamination, and the pollution rate that bottleneck in latter 7 days opened by eye drops reaches 49%.The pollution rate of foreign scholar to the investigation display eye drops of eye drops microbial contamination is 27% ~ 29%.Tasli etc. use the investigation of eye drops and 49 bottles of eye drops microbial contaminations of not opening in two weeks to find after opening 43 bottles, the microbial contamination rate of not opening the eye drops of use is 10.2%, and opening the pollution rate used is 34.8%.Wherein 6 bottles pollute staphylococcus, and 9 bottles pollute 1 to 2 kind of bacterium.Benzalkonium chloride (benzalkonium chloride) is used to be 34.4% as the eye drops contamination rate of anti fouling composition.In the eye drops do not opened, 2 bottles pollute staphylococcus aureus, and 2 bottles pollute lysozyme negative Staphylococcus, and 1 bottle pollutes Escherichia coli.The visible antiseptic power by the anti fouling composition in inspection eye drops is also unreliable, and antiseptic effect is undesirable.
3 ﹑ have certain toxic action
Foreign scholar's research compare containing anti fouling composition with not containing the anti-glaucoma eye drops of anti fouling composition to the toxicity of ocular tissue, result shows, in all uses not containing in the patient of anti fouling composition eye drops, pain, uncomfortable, itch, burn feeling, foreign body sensation, xerophthalmia, all remarkable patient lower than using containing anti fouling composition eye drops of incidence of the sings and symptoms such as to shed tears.There are some researches show, Long-Time Service can cause obvious conjunctival tissue to change containing the anti-glaucoma eye drops of anti fouling composition, and the success ratio of glaucoma filtration surgery can be made to decline.
4 ﹑ offset the therapeutic action of medicine to a certain extent
5, less economical
The unreasonable economy that makes of medicament for the eyes loading amount is also affected, and the medicament for the eyes remained in patient's hand can abandon, and not only wastes resource, adds the pollution of medical waste, certain economic loss that also made patient suffer.
Utility model content
The utility model aims to provide a kind of polyethylene eye drop bottle new structure, unit dose package, single use after opening, and safely, conveniently, cuts the waste, reduces the pollution of medical waste.
A kind of eye drop bottle new structure, comprises bottle, bottleneck, bottle cap, and described bottleneck connects bottle and bottle cap, there is the impression being easy to tear described bottle cap and bottleneck junction, be provided with opening board above bottle cap, opening board is fixedly connected with bottle cap, described bottle cross-sectional plane ovalize.
Further, the bottom of described bottle is elliposoidal.
Further, the bottom part down of described bottle is connected with designation plate.
Further, described designation plate is fixedly connected with the bottom of bottle, and designation plate is rectangular.
Further, the minor axis of the ellipse of described bottle cross-sectional plane is 7.0-9.5mm, and major axis is 11.0-13.5mm, and the height of bottle is different, and capacity is 0.1-1.5ml.
Preferably, the minor axis of the ellipse of described bottle cross-sectional plane is 7.3-9.3mm, and major axis is 11.1-13.1mm, and the height of bottle is different, and capacity is 0.2ml, 0.5ml, 1.0ml.
Further, eye drop bottle new structure 2-10 is connected side by side, and there is easily openable impression junction.
Further, eye drop bottle new structure is that hollow blow molding is one-body molded.
The utility model adopts unit dose package, single use after opening, safe, convenient, healthy, can reduce drug waste, reduces medical waste and pollutes, relieve patient ' s burden.
Accompanying drawing explanation
Fig. 1 is the utility model structural representation.
Fig. 2 is the left view of structure shown in Fig. 1.
In figure: 1-designation plate, the bottom of 2-bottle, 3-bottle, 4-bottleneck, 5-bottle cap, 6-opening board.
Detailed description of the invention
In order to make the purpose of this utility model, technical scheme and advantage clearly understand, below in conjunction with accompanying drawing, the utility model is further elaborated.
As shown in Figure 1, 2, a kind of eye drop bottle new structure, comprise bottle 3, bottleneck 4, bottle cap 5, described bottleneck 4 connects bottle 3 and bottle cap 5, described bottle cap 5 has with bottleneck 4 junction the impression being easy to tear, be provided with opening board 6 above bottle cap 5, opening board 6 is fixedly connected with bottle cap 5, described bottle 3 cross-sectional plane ovalize.
Further, the bottom 2 of described bottle is elliposoidal.
Further, below the bottom 2 of described bottle, be connected with designation plate 1, the product name of an article, lot number, date manufactured, subject word etc. can be indicated above.
Further, described designation plate 1 is fixedly connected with the bottom 2 of bottle, and designation plate 1 is rectangular.
Further, the minor axis of the ellipse of described bottle 3 cross-sectional plane is 7.0-9.5mm, and major axis is 11.0-13.5mm, and the height of bottle is different, and the capacity of bottle can be 0.1-1.5ml.
Preferably, the minor axis of the ellipse of described bottle 3 cross-sectional plane is 7.3-9.3mm, major axis is 11.1-13.1mm, and the height of bottle is different, and capacity is set to 0.1ml, 0.2ml, 0.3ml, 0.4ml, 0.5ml, 0.6ml, 0.8ml, 1.0ml, 1.2ml, 1.5ml etc.
Further, eye drop bottle new structure 2-10 is connected side by side, and there is easily openable impression junction.
Further, eye drop bottle new structure is that hollow blow molding is one-body molded.
Prepared by the utility model Low Density Polyethylene, quality is light, safe, nontoxic, tasteless, anti-impact force is strong, intensity is high, be conducive to storage and transport, can be compatible with most drug, the effective constituent of medicine can not be adsorbed, and can corrosion be tolerated, its refuse is free from environmental pollution, only need hold body during use, turn opening board and fracture completely to it, can use.
Certainly; the utility model also can have other various embodiments; when not deviating from the utility model spirit and essence thereof; those of ordinary skill in the art can make various corresponding change and distortion according to the utility model, but these change accordingly and are out of shape the protection domain that all should belong to the claim appended by the utility model.
Claims (8)
1. an eye drop bottle new structure, it is characterized in that: comprise bottle (3), bottleneck (4), bottle cap (5), described bottleneck (4) connects bottle (3) and bottle cap (5), there is the impression being easy to tear described bottle cap (5) and bottleneck (4) junction, bottle cap (5) top is provided with opening board (6), opening board (6) is fixedly connected with bottle cap (5), described bottle (3) cross-sectional plane ovalize.
2. eye drop bottle new structure according to claim 1, is characterized in that: the bottom (2) of described bottle is elliposoidal.
3. eye drop bottle new structure according to claim 1, is characterized in that: the below, bottom (2) of described bottle is connected with designation plate (1).
4. eye drop bottle new structure according to claim 3, is characterized in that: described designation plate (1) is fixedly connected with the bottom (2) of bottle, and designation plate (1) is rectangular.
5. eye drop bottle new structure according to claim 1, it is characterized in that: the minor axis of described bottle (3) cross-sectional plane ellipse is 7.0-9.5mm, major axis is 11.0-13.5mm, and the height of bottle is different, and the capacity of bottle can be 0.1-1.5ml.
6. eye drop bottle new structure according to claim 5, it is characterized in that: the minor axis of described bottle (3) cross-sectional plane ellipse is 7.3-9.3mm, major axis is 11.1-13.1mm, and the height of bottle is different, and capacity is 0.2ml, 0.5ml, 1.0ml.
7. eye drop bottle new structure according to claim 1, is characterized in that: eye drop bottle new structure is that hollow blow molding is one-body molded.
8. eye drop bottle new structure according to claim 1, is characterized in that: eye drop bottle new structure 2-10 is connected side by side, and there is easily openable impression junction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520135436.1U CN204473327U (en) | 2015-03-10 | 2015-03-10 | A kind of eye drop bottle new structure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520135436.1U CN204473327U (en) | 2015-03-10 | 2015-03-10 | A kind of eye drop bottle new structure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204473327U true CN204473327U (en) | 2015-07-15 |
Family
ID=53629123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520135436.1U Expired - Fee Related CN204473327U (en) | 2015-03-10 | 2015-03-10 | A kind of eye drop bottle new structure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204473327U (en) |
-
2015
- 2015-03-10 CN CN201520135436.1U patent/CN204473327U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9320802B2 (en) | Aqueous ophthalmic composition | |
| JP5951733B2 (en) | Ophthalmic composition | |
| US9173945B2 (en) | Ophthalmological aqueous composition | |
| CN101959500A (en) | Aqueous pharmaceutical compositions containing borate-polyol complexes | |
| CN101461777A (en) | Disposable levofloxacin hydrochloride eye drops without bacteriostatic agent and preparation method thereof | |
| Murphy et al. | Preparation, sterilization, and preservation of ophthalmic solutions: experimental studies and a practical method | |
| CN101461779A (en) | Disposable ofloxacin eye drops without bacteriostatic agent and preparation method thereof | |
| US20160243030A1 (en) | Aqueous Ophthalmic Composition | |
| CN101455633A (en) | Disposable levofloxacin lactate eye drops without bacteria inhibitor and preparation method thereof | |
| US20140005277A1 (en) | Aqueous ophthalmic composition | |
| CN101461776A (en) | Sodium hyaluronate eye drops without bacteriostatic agent and preparation method thereof | |
| CN204473327U (en) | A kind of eye drop bottle new structure | |
| CN101474146A (en) | Timolol maleate eye drops without bacteriostatic agent and preparation method thereof | |
| CN101455634A (en) | Composite aspartate, vitamin B6 and dipotassium glycyrrhetate eye drops without bacteria inhibitor and preparation method thereof | |
| JP2023009258A (en) | Ophthalmological preparation | |
| CN101461778A (en) | Disposable levofloxacin hydrochloride eye drops without bacteriostatic agent and preparation method thereof | |
| WO2019107569A1 (en) | Ophthalmic product | |
| CN101455635A (en) | Cromoglyn sodium eye drops without bacteria inhibitor and preparation method thereof | |
| CN101455639A (en) | Acyclovir eye drops without bacteria inhibitor and preparation method thereof | |
| TWI430799B (en) | Use of azithromycin for the manufacture of a medicament for treating tramchoma and process of manufacturing the treatment | |
| CN200973826Y (en) | Dropping bottle | |
| CN101461781A (en) | Gernebcin eye drops without bacteriostatic agent and preparation method thereof | |
| AU2010236505B2 (en) | Aqueous ophthalmic compositions containing anionic therapeutic agents | |
| Duffner et al. | Potential bacterial contamination in fluorescein-anesthetic solutions | |
| Frolova et al. | Development of the technology of vials-pencils for storage and application of medicated products on the skin and its appendages |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150715 |